New cancer drug BGB-24714 tested in early trial for solid tumors
NCT ID NCT05381909
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-phase study tested a new drug called BGB-24714, which is designed to help cancer cells die. It was given alone or with chemotherapy to 157 adults with advanced solid tumors that had spread or could not be removed. The main goal was to find a safe dose and see how well people tolerated the treatment. The study was terminated early, so full results may not be available.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
BGB-24714 (a drug that helps cancer cells die), given with or without chemotherapy drugs like paclitaxel, carboplatin, or docetaxel
What this could lead to
If it works, this could point toward a new treatment option for people with advanced solid tumors that have not responded to other therapies.
What could go wrong
This is a very early phase 1 trial, so the main goal is just to find a safe dose. It is too soon to know if the drug will actually shrink tumors or help patients live longer. The trial was also terminated early, so results may be limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Asan Medical Center
SongpaGu, Seoul Teugbyeolsi, 05505, South Korea
-
Auckland City Hospital
Auckland, 1023, New Zealand
-
Austin Health
Heidelberg, Victoria, VIC 3084, Australia
-
Avera Cancer Institute
Sioux Falls, South Dakota, 57105-2108, United States
-
Banner Md Anderson Cancer Center
Gilbert, Arizona, 85234-2165, United States
-
Barbara Ann Karmanos Cancer Institute
Detroit, Michigan, 48201-2013, United States
-
Chongqing Cancer Hospital
Chongqing, Chongqing Municipality, 400030, China
-
Florida Cancer Specialist (Scri) Sarasota
Sarasota, Florida, 34232, United States
-
Gachon University Gil Medical Center
NamdongGu, Incheon Gwang'yeogsi, 21565, South Korea
-
Hackensack University Medical Center
Hackensack, New Jersey, 07601-1915, United States
-
Henan Cancer Hospital
Zhengzhou, Henan, 450000, China
-
Hunan Cancer Hospital
Changsha, Hunan, 410013, China
-
Icon Cancer Centre South Brisbane
South Brisbane, Queensland, QLD 4101, Australia
-
Intermountain Healthcare
Salt Lake City, Utah, 84143, United States
-
Mary Crowley Cancer Research
Dallas, Texas, 75230, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
National Cancer Center (Korea)
IlsandongGu GoyangSi, Gyeonggi-do, 10408, South Korea
-
Next Virginia
Fairfax, Virginia, 22031, United States
-
Northern Beaches Hospital
Frenchs Forest, New South Wales, NSW 2086, Australia
-
Peter Maccallum Cancer Centre
Melbourne, Victoria, VIC 3000, Australia
-
Princess Alexandra Hospital
Woolloongabba, Queensland, QLD 4102, Australia
-
Samsung Medical Center
GangnamGu, Seoul Teugbyeolsi, 06351, South Korea
-
Sanford Cancer Center
Sioux Falls, South Dakota, 57104-4663, United States
-
Scri Florida Cancer Specialist East
West Palm Beach, Florida, 33401-3406, United States
-
Scri Florida Cancer Specialists North
St. Petersburg, Florida, 33705-1449, United States
-
Severance Hospital Yonsei University Health System
SeodaemunGu, Seoul Teugbyeolsi, 03722, South Korea
-
Shandong Cancer Hospital
Jinan, Shandong, 250117, China
-
Shandong Provincial Hospital
Jinan, Shandong, 250021, China
-
Sunshine Hospital
St Albans, Victoria, VIC 3021, Australia
-
Tennessee Oncology, Pllc Nashville
Nashville, Tennessee, 37203, United States
-
The University of Texas Md Anderson Cancer Center (Department Gi Medical Oncology)
Houston, Texas, 77030-4000, United States
-
University of Texas Southwestern Medical Center
Dallas, Texas, 75390-7208, United States
-
University of Washington
Seattle, Washington, 98195, United States
-
Upmc Hillman Cancer Center(Univ of Pittsburgh)
Pittsburgh, Pennsylvania, 15232-1309, United States